Clinical Priorities Advisory Group issues July 2020 prioritisation decisions

The Clinical Priorities Advisory Group has published its July 2020 round of prioritisation decisions.

Sufficient resources were deemed available to fund the treatments that fell into levels 1 and 2, which were: 

  • level 1: external beam radiotherapy for patients presenting with hormone sensitive, low volume metastatic prostate cancer at the time of diagnosis 
  • level 2: lung volume reduction by surgery or endobronchial valve for severe emphysema in adults.